Pancreatectomy After Neoadjuvant FOLFIRINOX Chemotherapy: Identifying Factors Predicting Long-Term Survival.
Pietro AddeoGerlinde AverousPierre de MathelinFrançois FaitotCaterina CusumanoChloe PaulPatrick DufourPhilippe BachellierPublished in: World journal of surgery (2023)
A multimodal treatment, including neoadjuvant FOLFIRINOX combined with pancreatectomy with venous and arterial resection, achieves long term survival rates in patients with locally advanced disease. Surgery, in experienced centers, should be integrated into the treatment of patients with locally advanced pancreatic adenocarcinomas.